MIRA
INFORM REPORT
|
Report Date : |
03.10.2007 |
IDENTIFICATION DETAILS
|
Name : |
ELIZABETH GLASER
PEDIATRIC AIDS FOUNDATION |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
10/9/1988 |
|
|
|
|
Com. Reg. No.: |
12284 |
|
|
|
|
Legal Form : |
Non Governmental
Organization |
|
|
|
|
Line of Business : |
Research,
Prevention and Treatment of HIV Virus to children etc |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 100,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY REPORTED
ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION
Principal Address
Telephone: +260-1256481
Fax: +260-1256481
Email: info@pedaids.org
Internet: www.pedaids.org
Established
10/9/1988
Registration
No. 12284
Legal Form
Non Governmental
Organization
Stock Listing
Not Listed
Workforce
2006
100
Office &
Factories
Head offices Plot #1210
Branches
Company Profile
Supported Fund USD. 1,000,000
Shareholders
Name Position Amount
Ratio
Mr. Paul Michael
Glaser Chairman
Dr. David Kessler Chairman
Mrs. Susan
DeLaurentis Director
Mrs. Susie Zeegen Director
Elizabeth Glaser
pediatric aids
Total 100.00%
Credit Opinion
Our proposed credit amount of USD 100,000 is recommendable
Affiliated Companies
Several Worldwide
Management/
Directors
|
President/
CEO (1) |
|
|
Name |
Mr. Paul Michael Glaser |
|
Remarks |
Top Decision Maker |
|
President/
CEO (2) |
|
|
Name |
Dr. David Kessler |
Þ Top decision maker is the person who has the ultimate authority or power to make important managerial decisions. He/She may or may not be officially registered as a president or an executive director.
Activities
Research,
Prevention and Treatment of HIV Virus to children etc
Terms of payment
Buying terms 20% in cash, 80% on credit
Selling terms 80% in cash, 20% on credit
Suppliers
ARV and other Research,
Aids Vaccines manufacturers
Customers
Children afflicted with the
HIV Virus
Recent public
support and revenue
USD. 72,000,000 (2006)
Banking
relationship
Main Banks Standard Chartered
Bank,
Credit Check of
Subject, President & CEO
(as of report date)
Payment Morale : In the documents at our
disposal nothing adverse has been shown so far.
CREDIT RATING : Financial situation is
average.
COMMENTS
According to its activities this is not a business enterprise, but a non Governmental organization established to curb the spread of HIV infections in children , The funds are obtained from well wishers and Supporters. Maximum credit we recommend is USD 100,000 outstanding at any one time.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to
assess SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)